“China’s drug ​regulator said on Monday it has ‌approved a CARsgen Therapeutics treatment for stomach cancer, a new milestone for CAR-T therapies, which engineer patients’ ​immune cells to recognise and kill cancer ​cells.

The injection, also known as satri-cel, is ⁠globally the first approved CAR-T cell therapy ​for solid tumors, CARsgen CEO Li Zonghai ​told Reuters in an interview after the announcement.”

From Reuters.